Merit's transradial Prelude sheath:
This article was originally published in Clinica
The US FDA has given Merit Medical Systems 510(k) market clearance to use its Prelude sheath introducer system in transradial catheterisation applications. "In many European, South American and Asian markets, this access method accounts for the majority of procedures," the South Jordan, Utah firm's chairman and CEO, Fred Lampropoulos, said of the transradial indication.
You may also be interested in...
Health technology assessment body NICE says that Revlimid fights cancer cells in a different way to current treatments which should help reduce resistance and improve disease outcomes.
As sector awaits its aducanumab filing with bated breath, Biogen invests again in early stage neuroscience.
In case you missed it: catch up with snippets from interviews with industry leaders recently published by In Vivo.